UK Markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
51.77-0.18 (-0.35%)
At close: 4:00PM EDT

51.77 0.00 (0.00%)
After hours: 4:00PM EDT

Full screen
Trade prices are not sourced from all markets
Previous close51.95
Bid51.72 x 900
Ask51.73 x 900
Day's range51.68 - 52.20
52-week range42.80 - 55.00
Avg. volume2,697,896
Market cap134.275B
Beta (5Y monthly)0.39
PE ratio (TTM)8.87
EPS (TTM)5.84
Earnings dateN/A
Forward dividend & yield1.91 (3.78%)
Ex-dividend date03 May 2021
1y target est63.88
  • Editor's pick
    Yahoo Finance Video

    CDC approves those fully vaccinated to largely ditch masks indoors

    Yahoo Finance’s Anjalee Khemlani reports the latest updates on the coronavirus.

  • Editor's pick
    Yahoo Finance Video

    CDC recommends Pfizer vaccine for children 12 to 15 years-old

    Dr. Brittani James, Co-Founder of The Institute for Antiracism in Medicine & Assistant Professor of Clinical Family Medicine at The University of Illinois College of Medicine, joins Yahoo Finance Live to discuss the latest on the coronavirus pandemic.

  • Is Sanofi a Good Buy in 2021?
    Motley Fool

    Is Sanofi a Good Buy in 2021?

    The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the space through the tremendous success of their drugs. Sanofi was actually a creation of several different companies, including Aventis, Synthélabo, Hoechst, Rhône-Poulenc Rorer, and several others. Through mergers and acquisitions (M&A) we got the Sanofi we know today.